Brain Neoplasms: all 1,993 studies
Page 3 of 20. Open to participants first (516), then studies with results posted, then the rest; newest registration first within each.
- Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain MetastasesRecruitingNCT06712927Phase 2
- Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain MetastasesRecruitingNCT06702826Phase 2
- A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)Not yet recruitingNCT06684873Phase 2
- Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain MetastasesNot yet recruitingNCT06683703Phase 2
- The Use of 5-ALA in Paediatric Patients With High Grade Brain TumoursNot yet recruitingNCT06678867Phase 2
- Brodalumab in the Treatment of Immune-Related Adverse EventsRecruitingNCT06673329Phase 1
- Magnetoencephalography in ChildrenRecruitingNCT06668519
- An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain TumorsRecruitingNCT06667726Phase 2
- Chronic CED of TPT for Recurrent Malignant GliomaRecruitingNCT06666712Phase 1
- Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain TumorsRecruitingNCT06650163Phase 1
- EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-activeRecruitingNCT06649058Phase 2
- Assessment of Cognitive Functions in Patients Receiving Whole Brain Radiotherapy in Assiut University Hospitals.Not yet recruitingNCT06646094
- TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and MeningiomasRecruitingNCT06640582Phase 1/2
- Window of Opportunity Study of DSP-0390 in GliomasRecruitingNCT06636162Early Phase 1
- Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness MeasurementsNot yet recruitingNCT06630338
- Key Longitudinal Associations With Risk and Glioblastoma OutcomesRecruitingNCT06625684
- Ex Vivo Drug Response Evaluation for Next Generation Care of Brain MetastasesRecruitingNCT06620380Phase 2
- Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First YearsRecruitingNCT06618703Not applicable
- Pilot IntraOperative Neuronal Electrophysiology in Tumor rElatEd suRgeryRecruitingNCT06617208Not applicable
- BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.RecruitingNCT06611306Not applicable
- AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain MetastasesRecruitingNCT06604689
- Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and AttentionRecruitingNCT06599879Not applicable
- JK-1201I in Triple Negative Breast Cancer Patients with Brain MetastasesNot yet recruitingNCT06586866Phase 2
- Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain MetastasisRecruitingNCT06582940Phase 2
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Evaluation of Postoperative Intracranial Pressure in Patients Undergoing Intracranial Tumor SurgeryNot yet recruitingNCT06559566Not applicable
- A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type GlioblastomaRecruitingNCT06552260Early Phase 1
- Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PETNot yet recruitingNCT06511323Not applicable
- Non-invasive Brain Tumor Molecular Diagnostics and MonitoringRecruitingNCT06501521
- Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain MetastasisRecruitingNCT06501391Phase 2
- Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges MetastaticNot yet recruitingNCT06497543Phase 2
- A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsRecruitingNCT06496971Phase 3
- Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain MetastasesNot yet recruitingNCT06483672Phase 2
- SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung CancerRecruitingNCT06476093Not applicable
- Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCsNot yet recruitingNCT06475443Phase 2
- Fluoroethyltyrosine for the Evaluation of Intracranial NeoplasmRecruitingNCT06474533
- Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain MetastasesRecruitingNCT06471465Phase 3
- Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]RecruitingNCT06466031Not applicable
- Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain MetastasesNot yet recruitingNCT06462079Phase 2
- SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLCRecruitingNCT06457906Phase 3
- Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal CancerRecruitingNCT06449989
- Short Versus Long-term Levetiracetam in Brain TumorsRecruitingNCT06442748Phase 3
- Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain MetastasisRecruitingNCT06418594Phase 2
- Comparing Cosmetic Outcomes: Endoscopic vs. Conventional Craniotomy for Frontal Skull Base LesionsNot yet recruitingNCT06417658Not applicable
- Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain MetastasesRecruitingNCT06405256
- Sacituzumab Govitecan and Bevacizumab for NSCLC Brain MetastasesRecruitingNCT06401824Phase 2
- Tracing Brain Tumors Through Deep TimeRecruitingNCT06381531
- Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain MetastasesNot yet recruitingNCT06374888Phase 2
- Visual Telerehabilitation in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain TumourNot yet recruitingNCT06362434Not applicable
- 99mTc-CNDG SPECT/CT in Brain TumorsRecruitingNCT06362304Not applicable
- SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain MetastasesNot yet recruitingNCT06361979Phase 2
- Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal AssessmentRecruitingNCT06352710
- An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain MetastasisRecruitingNCT06352502
- Brain Metastasis Development Mechanism in BCBM PatientsRecruitingNCT06330870Not applicable
- Improving Social Cognition and Social Behaviour in Various Brain DisordersRecruitingNCT06330298Not applicable
- Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain MetastasesRecruitingNCT06328686Early Phase 1
- Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain TumorsRecruitingNCT06322602Not applicable
- High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain MetastasesNot yet recruitingNCT06319950Phase 2
- Surgical Resection Outcomes in Patients With Brain MetastasisRecruitingNCT06318065
- Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain MetastasisRecruitingNCT06315010Phase 2
- Genetic and Molecular Characterization of Nervous System LesionsRecruitingNCT06314607
- Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric PatientsRecruitingNCT06309251
- Autoguide Positioning Device for Multiple Stereotactic BiopsiesRecruitingNCT06306118
- Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D PrintingRecruitingNCT06291662Not applicable
- FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor PatientsRecruitingNCT06282562Not applicable
- Multi-disciplinary Care for Brain MetastasesRecruitingNCT06280300Not applicable
- The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent GlioblastomaRecruitingNCT06273176
- ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult PatientsRecruitingNCT06254326Phase 1
- A Phase 1/1b Study of IAM1363 in HER2 CancersRecruitingNCT06253871Phase 1
- MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast CancerRecruitingNCT06247449Not applicable
- WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain MetastasesRecruitingNCT06243003Phase 1/2
- Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.RecruitingNCT06238882Not applicable
- a Feasibility Study of iHD-SRT for BMRecruitingNCT06231186Not applicable
- The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In CraniotomiesRecruitingNCT06229483Phase 3
- SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain MetastasesNot yet recruitingNCT06210438Phase 2
- Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous MelanomaRecruitingNCT06194929Phase 1/2
- Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor PatientsRecruitingNCT06185686
- Guided Meditation During Radiation Therapy for Brain TumorsRecruitingNCT06165653Not applicable
- Study of Olutasidenib and Temozolomide in HGGRecruitingNCT06161974Phase 2
- PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN AmplificationsRecruitingNCT06161519Phase 1/2
- 18F-FLUC PET/MR in Patients With Brain MetsRecruitingNCT06159335Phase 3
- Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain MetastasesRecruitingNCT06152822Phase 2
- A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain MetastasesRecruitingNCT06136884Phase 1
- Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS TrialRecruitingNCT06132685Phase 2
- Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid TumorsRecruitingNCT06128148Phase 1
- The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)RecruitingNCT06118723
- Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only WorkflowNot yet recruitingNCT06106997Not applicable
- Development of MRF for Characterization of Brain Tumors After RadiotherapyRecruitingNCT06101069Not applicable
- Supportive Psychoeducational Intervention for Patients With Brain Tumors (Acceptance and Commitment Therapy-based Supportive Intervention for Patients With Central Nervous System Tumors)RecruitingNCT06099743Not applicable
- Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/DiseaseRecruitingNCT06092125
- A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain MetastasesNot yet recruitingNCT06088056Phase 2
- CONVIVO EndomicroscopyRecruitingNCT06087393Not applicable
- Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast CancerRecruitingNCT06072807Phase 4
- Trastuzumab Deruxtecan (T-DXd) for People With Brain CancerRecruitingNCT06058988Phase 2
- Feasibility of 18F-Fluciclovine PET/CT to Identify Brain MetastasisRecruitingNCT06055790Early Phase 1
- Lithium Treatment to Prevent Cognitive Impairment After Brain RadiotherapyRecruitingNCT06051240Phase 2
- 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic RadiosurgeryRecruitingNCT06048094Phase 1
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
- Preclinical Brain Tumor ModelsRecruitingNCT06045065
- Sonodynamic Therapy in Patients With Recurrent GBMRecruitingNCT06039709Phase 1